Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

被引：19
作者：
Kow, Chia Siang [1 ]
Zaidi, Syed Tabish Razi [2 ]
Hasan, Syed Shahzad [3 ]
机构：
[1] Int Med Univ, Fac Med & Hlth Sci, Kuala Lumpur, Malaysia
[2] Univ Leeds, Sch Healthcare, Leeds, W Yorkshire, England
[3] Univ Huddersfield, Sch Appl Sci, Huddersfield, W Yorkshire, England
来源：
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 2020年 / 20卷 / 03期
关键词：
CONVERTING ENZYME 2; MYOCARDIAL-INFARCTION; SARS-CORONAVIRUS; ACE2; EXPRESSION; RECEPTOR BLOCKERS; BLOCKADE;
D O I：
10.1007/s40256-020-00406-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19.
引用
收藏
页码：217 / 221
页数：5
相关论文
共 41 条
  • [1] [Anonymous], [No title captured]
  • [2] [Anonymous], LANCET RESP MED
  • [3] [Anonymous], The Lancet
  • [4] [Anonymous], ALLERGY
  • [5] [Anonymous], CORONAVIRUS CONUNDRU
  • [6] Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions
    Burchill, Luke J.
    Velkoska, Elena
    Dean, Rachael G.
    Griggs, Karen
    Patel, Sheila K.
    Burrell, Louise M.
    [J]. CLINICAL SCIENCE, 2012, 123 (11-12) : 649 - 658
  • [7] Myocardial infarction increases ACE2 expression in rat and humans
    Burrell, LM
    Risvanis, J
    Kubota, E
    Dean, RG
    MacDonald, PS
    Lu, S
    Tikellis, C
    Grant, SL
    Lew, RA
    Smith, AI
    Cooper, ME
    Johnston, CI
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (04) : 369 - 375
  • [8] An interactive web-based dashboard to track COVID-19 in real time
    Dong, Ensheng
    Du, Hongru
    Gardner, Lauren
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (05) : 533 - 534
  • [9] Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes
    Epelman, Slava
    Shrestha, Kevin
    Troughton, Richard W.
    Francis, Gary S.
    Sen, Subha
    Klein, Allan L.
    Tang, W. H. Wilson
    [J]. JOURNAL OF CARDIAC FAILURE, 2009, 15 (07) : 565 - 571
  • [10] Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
    Ferrario, CM
    Jessup, J
    Chappell, MC
    Averill, DB
    Brosnihan, KB
    Tallant, EA
    Diz, DI
    Gallagher, PE
    [J]. CIRCULATION, 2005, 111 (20) : 2605 - 2610
12345